{"pub": "reuters", "url": "https://uk.reuters.com/article/uk-circassia-pharma-stake-woodford/woodford-discloses-less-than-5-stake-in-circassia-pharmaceuticals-filing-idUKKBN1W126J", "downloaded_at": "2019-09-17 10:41:01.020194+00:00", "title": "Woodford discloses less than 5% stake in Circassia Pharmaceuticals - filing", "language": "en", "text": "(This September 16 story corrects third paragraph to say Woodford Investment Management, not Woodford Patient Capital Trust, has been under pressure from lawmakers and investors.)\n\n(Reuters) - British asset manager Woodford Investment Management Ltd disclosed a less than 5% stake in Circassia Pharmaceuticals Plc (CIRCI.L) as of Sept. 13, a filing showed on Monday.\n\nWoodford earlier held a 19.95% stake in the speciality biopharmaceutical company, according to the filing.\n\nWoodford Investment Management has been under pressure from lawmakers and investors for not being able to meet redemption requests, after the flagship equity income fund was frozen in June.", "description": "(This September 16 story corrects third paragraph to say Woodford Investment Management, not Woodford Patient Capital Trust, has been under pressure from lawmakers and investors.)", "authors": ["Reuters Editorial", "Min Read"], "top_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "published_at": "2019-09-17"}